180 related articles for article (PubMed ID: 20578181)
1. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.
Habeeb O; Goodglick L; Soslow RA; Rao RG; Gordon LK; Schirripa O; Horvath S; Braun J; Seligson DB; Wadehra M
Cancer; 2010 Oct; 116(20):4718-26. PubMed ID: 20578181
[TBL] [Abstract][Full Text] [Related]
2. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
[TBL] [Abstract][Full Text] [Related]
4. ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas.
Mah V; Elshimali Y; Chu A; Moatamed NA; Uzzell JP; Tsui J; Schettler S; Shakeri H; Wadehra M
Sci Rep; 2021 Jun; 11(1):11949. PubMed ID: 34099751
[TBL] [Abstract][Full Text] [Related]
5. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Shimazaki K; Lepin EJ; Wei B; Nagy AK; Coulam CP; Mareninov S; Fu M; Wu AM; Marks JD; Braun J; Gordon LK; Wadehra M
Clin Cancer Res; 2008 Nov; 14(22):7367-77. PubMed ID: 19010852
[TBL] [Abstract][Full Text] [Related]
6. Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium.
Sehitoglu I; Bedir R; Ural UM; Gucer H; Yurdakul C; Cure MC; Cure E; Yuce S; Sahin FK
Asian Pac J Cancer Prev; 2015; 16(4):1495-9. PubMed ID: 25743820
[TBL] [Abstract][Full Text] [Related]
7. EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH; Dillard C; Tsui J; Kim SR; Lu J; Sachdev D; Goodglick L; Tong M; Torous VF; Aryasomayajula C; Wang W; Najafzadeh P; Gordon LK; Braun J; McDermott S; Wicha MS; Wadehra M
Oncogene; 2017 Oct; 36(42):5793-5807. PubMed ID: 28604744
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.
Fu M; Brewer S; Olafsen T; Wu AM; Gordon LK; Said J; Braun J; Wadehra M
Mol Imaging Biol; 2013 Feb; 15(1):68-78. PubMed ID: 22585360
[TBL] [Abstract][Full Text] [Related]
9. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
[TBL] [Abstract][Full Text] [Related]
10. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.
Gordon LK; Kiyohara M; Fu M; Braun J; Dhawan P; Chan A; Goodglick L; Wadehra M
Oncogene; 2013 Nov; 32(46):5369-76. PubMed ID: 23334331
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas.
Chung LK; Pelargos PE; Chan AM; Demos JV; Lagman C; Sheppard JP; Nguyen T; Chang YL; Hojat SA; Prins RM; Liau LM; Nghiemphu L; Lai A; Cloughesy TF; Yong WH; Gordon LK; Wadehra M; Yang I
Brain Tumor Pathol; 2018 Jan; 35(1):1-9. PubMed ID: 28887715
[TBL] [Abstract][Full Text] [Related]
12. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Eukaryotic Translation Initiation Factors (eIFs) in Endometrial Cancer.
Smolle MA; Czapiewski P; Lapińska-Szumczyk S; Majewska H; Supernat A; Zaczek A; Biernat W; Golob-Schwarzl N; Haybaeck J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817792
[TBL] [Abstract][Full Text] [Related]
14. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
Cha YJ; Koo JS
PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
[TBL] [Abstract][Full Text] [Related]
15. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
16. Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development.
Sullivan PS; Maresh EL; Seligson DB; Habeeb O; Wadehra M; Goodglick L; Dorigo O
Mod Pathol; 2012 Aug; 25(8):1140-8. PubMed ID: 22460811
[TBL] [Abstract][Full Text] [Related]
17. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormone regulation of EMP2 expression and localization in the endometrium.
Wadehra M; Mainigi M; Morales SA; Rao RG; Gordon LK; Williams CJ; Braun J
Reprod Biol Endocrinol; 2008 Apr; 6():15. PubMed ID: 18400107
[TBL] [Abstract][Full Text] [Related]
19. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
20. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]